DK0914153T3 - Multivalente DTP-poliovacciner - Google Patents

Multivalente DTP-poliovacciner

Info

Publication number: DK0914153T3
Authority: DK; Denmark
Prior art keywords: vaccine; components; toxoid; component; polio vaccines
Prior art date: 1996-07-02

Application number

DK97928089T

Other languages

Danish (da)

English (en)

Inventor

Raafat E F Fahim

Luis Barreto

Larry U L Tan

John Thipphawong

Gail E D Jackson

Original Assignee

Sanofi Pasteur Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-02

Filing date

1997-07-02

Publication date

2007-01-29

1996-07-02 Priority claimed from US08/672,530 external-priority patent/US6696065B1/en

1997-07-02 Application filed by Sanofi Pasteur Ltd filed Critical Sanofi Pasteur Ltd

2007-01-29 Application granted granted Critical

2007-01-29 Publication of DK0914153T3 publication Critical patent/DK0914153T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Mycology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

DK97928089T 1996-07-02 1997-07-02 Multivalente DTP-poliovacciner DK0914153T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/672,530 US6696065B1 (en)	1995-05-04	1996-07-02	Acellular pertussis vaccines and methods of preparation thereof
PCT/CA1997/000472 WO1998000167A1 (en)	1996-07-02	1997-07-02	Multivalent dtp-polio vaccines

Publications (1)

Publication Number	Publication Date
DK0914153T3 true DK0914153T3 (da)	2007-01-29

Family

ID=24698948

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97928089T DK0914153T3 (da)	1996-07-02	1997-07-02	Multivalente DTP-poliovacciner

Country Status (20)

Country	Link
EP (2)	EP1762246A1 (de)
JP (4)	JP3280675B2 (de)
CN (2)	CN101310769B (de)
AT (1)	ATE339965T1 (de)
AU (1)	AU714493B2 (de)
BR (2)	BRPI9710460B8 (de)
CA (1)	CA2259415A1 (de)
DE (1)	DE69736709T2 (de)
DK (1)	DK0914153T3 (de)
ES (1)	ES2271969T3 (de)
IL (1)	IL127847A (de)
NZ (1)	NZ333989A (de)
PL (1)	PL187935B1 (de)
PT (1)	PT914153E (de)
RO (1)	RO120819B1 (de)
RU (1)	RU2194531C2 (de)
SI (1)	SI9720050B (de)
SK (1)	SK283565B6 (de)
TR (1)	TR199802783T2 (de)
WO (1)	WO1998000167A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU4707097A (en) *	1997-09-15	1999-04-05	Pasteur Merieux Serums Et Vaccins	Multivalent vaccines
EP1004314A1 (de) *	1998-11-26	2000-05-31	Pasteur Merieux MSD	T.d.Polio Impstoff für einer primovakzinierter oder empfindlicher Population
GB0108364D0 (en) *	2001-04-03	2001-05-23	Glaxosmithkline Biolog Sa	Vaccine composition
KR100401423B1 (ko) *	2001-01-10	2003-10-17	주식회사 엘지생명과학	혼합 백신의 제조 방법
MXPA05004528A (es)	2002-11-01	2005-07-26	Glaxosmithkline Biolog Sa	Composicion inmunogenica.
RU2240819C2 (ru) *	2003-01-04	2004-11-27	Государственное учреждение Научно-исследовательский институт медицинских проблем Севера СО РАМН	Способ вакцинопрофилактики коклюша, дифтерии и столбняка на крайнем севере
RU2228200C1 (ru) *	2003-01-20	2004-05-10	Красноярская государственная медицинская академия	Способ профилактики акдс-вакциной на крайнем севере
GB0313916D0 (en)	2003-06-16	2003-07-23	Glaxosmithkline Biolog Sa	Vaccine composition
EP1489092A1 (de) *	2003-06-18	2004-12-22	Institut Pasteur	Modifizierte Bordetella Adenylatcyclase mit oder ohne CD11b/CD18 Interaktionsdomäne und seine Verwendungen
US7901921B2 (en) *	2004-10-22	2011-03-08	Oncolytics Biotech Inc.	Viral purification methods
GB0616306D0 (en) *	2006-08-16	2006-09-27	Novartis Ag	Vaccines
GB0617602D0 (en) *	2006-09-07	2006-10-18	Glaxosmithkline Biolog Sa	Vaccine
EA015964B1 (ru) *	2006-09-07	2012-01-30	Глаксосмитклайн Байолоджикалс С.А.	Вакцина
KR101617464B1 (ko)	2006-09-29	2016-05-02	잇판사이단호진한다이비세이부쯔뵤우겐큐우카이	Ｉｐｖ―ｄｐｔ 백신
WO2009016651A1 (en) *	2007-07-31	2009-02-05	Panacea Biotec Limited	Simplified means for obtaining prn from bordetella pertussis
JP5511660B2 (ja)	2008-06-04	2014-06-04	一般財団法人化学及血清療法研究所	不活化日本脳炎ウイルス粒子をアジュバントとして使用する方法
PE20100365A1 (es)	2008-10-24	2010-05-21	Panacea Biotec Ltd	Novedosas vacunas de combinacion con tos ferina de celulas enteras y metodo para su elaboracion
PE20100366A1 (es) *	2008-10-24	2010-05-21	Panacea Biotec Ltd	Novedosas composiciones de vacuna con tos ferina acelular asi como el metodo para su elaboracion
US20100330158A1 (en) *	2009-03-31	2010-12-30	Innopharma, Llc	Protein-assisted drug delivery system for the targeted administration of active agents
RU2013136397A (ru)	2011-01-05	2015-02-10	Бхарат Байотек Интернэшнл Лимитед	Комбинированная семивалентная вакцина
PT2670432T (pt) *	2011-02-04	2021-05-04	Zoetis Services Llc	Composições imunogénicas de bordetella bronchiseptica
GB201106225D0 (en)	2011-04-13	2011-05-25	Glaxosmithkline Biolog Sa	Fermentation process
CN102861330B (zh) *	2012-06-29	2014-10-29	成都欧林生物科技股份有限公司	一种Hib多糖与精制破伤风类毒素偶联工艺
CA2886938A1 (en) *	2012-10-12	2014-04-17	Glaxosmithkline Biologicals S.A.	Non-cross-linked acellular pertussis antigens for use in combination vaccines
CN103007264A (zh) *	2012-12-14	2013-04-03	北京民海生物科技有限公司	b型流感嗜血杆菌结合疫苗及其应用
WO2014102265A1 (en)	2012-12-27	2014-07-03	Glycovaxyn Ag	Methods and compositions relating to crm197
CN105007936B (zh) *	2013-03-08	2018-10-02	扬森疫苗与预防公司	无细胞百日咳疫苗
US9849066B2 (en)	2013-04-24	2017-12-26	Corning Incorporated	Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
AR101256A1 (es)	2014-07-21	2016-12-07	Sanofi Pasteur	Composición vacunal que comprende ipv y ciclodextrinas
EP3204494B1 (de) *	2014-10-07	2020-04-01	Serum Institute Of India Private Limited	Verbesserte methoden zur poliovirusinaktivierung, adjuvantadsorption
RU2626532C2 (ru) *	2015-01-16	2017-07-28	Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации	Комбинированная вакцина для профилактики коклюша, дифтерии, столбняка, гепатита в и инфекции, вызываемой haemophilus influenzae тип в
RU2596919C2 (ru) *	2015-01-16	2016-09-10	Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации	Комбинированная вакцина для профилактики коклюша, дифтерии, столбняка
CN104707134A (zh) *	2015-03-27	2015-06-17	成都欧林生物科技股份有限公司	一种无细胞百日破联合疫苗及其制备方法
CN108570098B (zh) *	2017-12-29	2021-09-07	武汉生物制品研究所有限责任公司	一种百日咳多种抗原成分的分离纯化方法
WO2020165920A1 (en) *	2019-02-12	2020-08-20	Biological E Limited	Multivalent vaccine composition
WO2020236973A1 (en)	2019-05-20	2020-11-26	Soligenix, Inc.	Compositions and methods of manufacturing trivalent filovirus vaccines
CN111000994A (zh) *	2019-12-26	2020-04-14	北京科兴中维生物技术有限公司	一种液体疫苗组合物及其制备方法与应用
CN111053898B (zh) *	2019-12-26	2023-05-16	北京科兴中维生物技术有限公司	一种疫苗组合物及其应用
WO2021176409A1 (en)	2020-03-05	2021-09-10	Sanofi Healthcare India Private Limited	Preservative combination for vaccine composition

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3097140A (en) *	1958-10-31	1963-07-09	Merck & Co Inc	Preparing a mixed polio, pertussis, tetanus, and diphtheria vaccine with benzethonium chloride
US4258029A (en)	1979-04-23	1981-03-24	Connaught Laboratories Limited	Synthetic adjuvants for stimulation of antigenic responses
DE3521994A1 (de)	1985-06-20	1987-01-02	Bayer Ag	N-(2-aminoacylamido-2-desoxy-hexosyl)-amide-, -carbamate und -harnstoffe, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4705686A (en)	1986-05-09	1987-11-10	American Cyanamid	Process for the preparation of acellular Bordetalla pertussis vaccine
GB8727489D0 (en)	1987-11-24	1987-12-23	Connaught Lab	Detoxification of pertussis toxin
GB8807860D0 (en)	1988-04-05	1988-05-05	Connaught Lab	Pertussis vaccine
US5101014A (en)	1989-02-10	1992-03-31	United States Of America	Process for the purification of a 69,000 da outer membrane protein of Bordetella pertussis
US5276142A (en)	1989-12-11	1994-01-04	American Cyanamid Company	Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis
GB9007657D0 (en)	1990-04-04	1990-05-30	Connaught Lab	Purification of a pertussis outer membrane protein(omp69)
EP0484621A3 (en) *	1990-07-11	1992-08-26	American Cyanamid Company	Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
IL101692A0 (en) *	1991-05-03	1992-12-30	Amgen Inc	Recombinant b oligomer of pertussis toxin
DE69319728T2 (de)	1992-05-23	1999-02-04	Smithkline Beecham Biologicals S.A., Rixensart	Kombinierte Impfstoffe, die Hepatitis B oberfläche Antigen und andere Antigenen enthalten
ES2126616T3 (es) *	1992-10-27	1999-04-01	American Cyanamid Co	Vacuna pediatrica combinada, con una inmunogenecidad aumentada de cada componente de la vacuna.
PT1393744E (pt) *	1995-05-04	2011-05-03	Sanofi Pasteur Ltd	Vacinas acelulares contra a tosse convulsa e m?todos para a sua prepara??o
NZ311000A (en) *	1995-06-07	1999-04-29	Smithkline Beecham Biolog	Vaccine comprising a polysaccharide antigen-carrier protein conjugate and a free carrier protein
IL122588A (en) *	1995-06-23	2001-12-23	Smithkline Beecham Biolog	A combination vaccine containing a polysaccharide conjugated antigen attached to a phosphate aluminum and one or more additional antibodies

1997
- 1997-07-02 CA CA002259415A patent/CA2259415A1/en not_active Abandoned
- 1997-07-02 AU AU32516/97A patent/AU714493B2/en not_active Expired
- 1997-07-02 TR TR1998/02783T patent/TR199802783T2/xx unknown
- 1997-07-02 BR BRPI9710460A patent/BRPI9710460B8/pt unknown
- 1997-07-02 AT AT97928089T patent/ATE339965T1/de active
- 1997-07-02 IL IL12784797A patent/IL127847A/en not_active IP Right Cessation
- 1997-07-02 NZ NZ333989A patent/NZ333989A/en not_active IP Right Cessation
- 1997-07-02 WO PCT/CA1997/000472 patent/WO1998000167A1/en not_active Ceased
- 1997-07-02 SI SI9720050A patent/SI9720050B/sl not_active IP Right Cessation
- 1997-07-02 BR BR9710460A patent/BR9710460A/pt not_active IP Right Cessation
- 1997-07-02 PL PL33100797A patent/PL187935B1/pl unknown
- 1997-07-02 JP JP50369098A patent/JP3280675B2/ja not_active Expired - Lifetime
- 1997-07-02 CN CN200810125160.3A patent/CN101310769B/zh not_active Expired - Lifetime
- 1997-07-02 EP EP06019398A patent/EP1762246A1/de not_active Withdrawn
- 1997-07-02 DE DE69736709T patent/DE69736709T2/de not_active Expired - Lifetime
- 1997-07-02 RO RO98-01772A patent/RO120819B1/ro unknown
- 1997-07-02 PT PT97928089T patent/PT914153E/pt unknown
- 1997-07-02 SK SK1818-98A patent/SK283565B6/sk not_active IP Right Cessation
- 1997-07-02 DK DK97928089T patent/DK0914153T3/da active
- 1997-07-02 RU RU99101850/14A patent/RU2194531C2/ru active
- 1997-07-02 CN CNB971976090A patent/CN100408095C/zh not_active Expired - Lifetime
- 1997-07-02 EP EP97928089A patent/EP0914153B8/de not_active Expired - Lifetime
- 1997-07-02 ES ES97928089T patent/ES2271969T3/es not_active Expired - Lifetime
2001
- 2001-08-15 JP JP2001246781A patent/JP2002069002A/ja not_active Withdrawn
2006
- 2006-06-14 JP JP2006165354A patent/JP2006241171A/ja not_active Withdrawn
2011
- 2011-02-07 JP JP2011024221A patent/JP2011121981A/ja active Pending

Also Published As

Publication number	Publication date
BRPI9710460B8 (pt)	2021-05-25
AU3251697A (en)	1998-01-21
CN101310769A (zh)	2008-11-26
EP0914153B1 (de)	2006-09-20
CN100408095C (zh)	2008-08-06
CA2259415A1 (en)	1998-01-08
PL331007A1 (en)	1999-06-21
AU714493B2 (en)	2000-01-06
RO120819B1 (ro)	2006-08-30
JP2011121981A (ja)	2011-06-23
SK283565B6 (sk)	2003-09-11
PL187935B1 (pl)	2004-11-30
IL127847A (en)	2004-06-01
ATE339965T1 (de)	2006-10-15
BR9710460A (pt)	1999-08-17
NZ333989A (en)	2000-06-23
EP0914153A1 (de)	1999-05-12
JP3280675B2 (ja)	2002-05-13
JP2000504032A (ja)	2000-04-04
SI9720050B (en)	2001-12-31
CN1228709A (zh)	1999-09-15
WO1998000167A1 (en)	1998-01-08
RU2194531C2 (ru)	2002-12-20
BRPI9710460B1 (pt)	2019-02-05
DE69736709T2 (de)	2007-10-04
SI9720050A (sl)	1999-12-31
EP1762246A1 (de)	2007-03-14
JP2002069002A (ja)	2002-03-08
ES2271969T3 (es)	2007-04-16
SK181898A3 (en)	2000-05-16
CN101310769B (zh)	2015-11-25
TR199802783T2 (xx)	1999-03-22
IL127847A0 (en)	1999-10-28
PT914153E (pt)	2007-01-31
DE69736709D1 (de)	2006-11-02
JP2006241171A (ja)	2006-09-14
EP0914153B8 (de)	2006-11-02

Publication	Publication Date	Title
DE69736709D1 (de)	2006-11-02	Vielwertige dtp-polio-impfstoffe
SI1296715T1 (sl)	2012-03-30	Multivalentni sestavek cepiva
ATE316797T1 (de)	2006-02-15	Verfahren zur herstellung multivalenter impfstoffe
LU91596I2 (fr)	2009-10-12	Combinaison d'anatoxine diphtérique, d'anatoxine tétanique,d'antoxine coquelucheuse, d'hémagglutinine filamenteuse, de pertactine, de virus poliomyélitique inactivé type 1, type 2 et type 3 et de polyoside capsulaire d'haemophilus influenzae type b (Infanrix - IPV/Hib)
DK0764029T4 (da)	2008-07-28	Proteinadjuvanser
NO2006005I1 (no)	2006-05-08	Difteri-,tetanus-, acellulære kikhoste- og polioantigener
UA27754C2 (uk)	2000-10-16	Комбінована педіатрична вакцина, спосіб одночасної комбінованої вакцинації
EP0338265A3 (en)	1989-12-13	Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine
WO2000051633A3 (en)	2001-01-25	MULTI-COMPONENT VACCINE COMPRISING AT LEAST THREE ANTIGENS TO PROTECT AGAINST DISEASE CAUSED BY $i(HAEMOPHILUS INFLUENZAE)